JP2015521628A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521628A5
JP2015521628A5 JP2015518633A JP2015518633A JP2015521628A5 JP 2015521628 A5 JP2015521628 A5 JP 2015521628A5 JP 2015518633 A JP2015518633 A JP 2015518633A JP 2015518633 A JP2015518633 A JP 2015518633A JP 2015521628 A5 JP2015521628 A5 JP 2015521628A5
Authority
JP
Japan
Prior art keywords
vlp
solution
norovirus
subpopulation
chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015518633A
Other languages
English (en)
Japanese (ja)
Other versions
JP6553509B2 (ja
JP2015521628A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/047249 external-priority patent/WO2013192604A1/en
Publication of JP2015521628A publication Critical patent/JP2015521628A/ja
Publication of JP2015521628A5 publication Critical patent/JP2015521628A5/ja
Application granted granted Critical
Publication of JP6553509B2 publication Critical patent/JP6553509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015518633A 2012-06-22 2013-06-24 ウイルス様粒子の精製 Active JP6553509B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261663218P 2012-06-22 2012-06-22
US61/663,218 2012-06-22
US201361794086P 2013-03-15 2013-03-15
US61/794,086 2013-03-15
PCT/US2013/047249 WO2013192604A1 (en) 2012-06-22 2013-06-24 Purification of virus like particles

Publications (3)

Publication Number Publication Date
JP2015521628A JP2015521628A (ja) 2015-07-30
JP2015521628A5 true JP2015521628A5 (enExample) 2016-08-12
JP6553509B2 JP6553509B2 (ja) 2019-07-31

Family

ID=49769461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518633A Active JP6553509B2 (ja) 2012-06-22 2013-06-24 ウイルス様粒子の精製

Country Status (15)

Country Link
US (3) US10167320B2 (enExample)
EP (1) EP2864478B1 (enExample)
JP (1) JP6553509B2 (enExample)
KR (1) KR102110876B1 (enExample)
CN (2) CN114085273B (enExample)
AR (1) AR091538A1 (enExample)
AU (1) AU2013277959B2 (enExample)
CA (1) CA2879815A1 (enExample)
IN (1) IN2015DN00089A (enExample)
JO (1) JOP20130186B1 (enExample)
MX (1) MX366234B (enExample)
SG (2) SG11201408459VA (enExample)
TW (1) TWI647310B (enExample)
UY (1) UY34875A (enExample)
WO (1) WO2013192604A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2577833T3 (es) 2006-09-29 2016-07-19 Takeda Vaccines, Inc. Formulaciones de vacuna para norovirus
HUE028605T2 (en) 2007-03-14 2016-12-28 Takeda Vaccines Inc Cleaning virus-like particles
SG10201601660YA (en) 2007-09-18 2016-04-28 Takeda Vaccines Inc Method of conferring a protective immune response to norovirus
EP3299030B1 (en) 2011-07-11 2022-06-08 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
CN105339495A (zh) * 2013-07-11 2016-02-17 宝生物工程株式会社 制备无包膜病毒的方法
AU2014329403B2 (en) 2013-10-03 2020-10-08 Takeda Vaccines, Inc. Methods of detection and removal of rhabdoviruses from cell lines
CN103981084B (zh) * 2014-05-29 2015-11-18 黑龙江省科学院微生物研究所 水中病毒分离提取装置及水中札幌病毒的提取方法
CN107109374B (zh) 2015-01-09 2021-04-06 宝生物工程株式会社 用于生产无包膜病毒颗粒的方法
US10920288B2 (en) 2015-01-16 2021-02-16 Takeda Vaccines, Inc. Detection of particle-contained reverse transcriptase activity
CN105907729B (zh) * 2015-05-05 2019-08-16 广东东阳光药业有限公司 一种制备人乳头瘤病毒l1蛋白类病毒样颗粒的方法
CN107034198B (zh) * 2015-07-15 2021-03-09 长春百克生物科技股份公司 一种嵌合诺如病毒p颗粒及其制备和应用
CA3000329A1 (en) 2015-08-28 2017-03-09 Ology Bioservices, Inc. Norovirus vaccine
CN105779399A (zh) * 2016-03-28 2016-07-20 广西壮族自治区林业科学研究院 一种昆虫杆状病毒纯化方法
GB201614050D0 (en) 2016-08-17 2016-09-28 Glaxosmithkline Ip Dev Ltd Method for purifying viral vectors
KR20190042606A (ko) * 2016-09-01 2019-04-24 다케다 백신즈 인코포레이티드 백신 제조용 바이러스의 제조 방법
EP3420076B1 (en) * 2017-03-06 2024-02-21 Guangzhou Realbenefitspot Pharmaceutical Co., Ltd. Methods of producing and characterizing virus vaccine and virus vaccine composition
EP4382183A3 (en) 2017-03-06 2024-08-21 Guangzhou Realbenefitspot Pharmaceutical Co., Ltd. Methods of producing and characterizing virus vaccine and virus vaccine composition
US11633467B2 (en) 2018-02-15 2023-04-25 Icon Genetics Gmbh Immunogenic composition and vaccine for generating an immune response to norovirus
CN108676781A (zh) * 2018-05-18 2018-10-19 山东信得动物疫苗有限公司 一种重组禽流感病毒的工业化纯化方法
CN108776225A (zh) * 2018-05-23 2018-11-09 中国农业科学院兰州兽医研究所 猪细小病毒VLPs抗体检测试剂盒及其制备方法、应用
US20220152186A1 (en) 2019-03-12 2022-05-19 Icon Genetics Gmbh Norovirus-like particles with improved stability
US12403164B2 (en) 2019-09-30 2025-09-02 Bioverativ Therapeutics Inc. Lentiviral vector formulations
EP4340874A1 (en) 2021-05-21 2024-03-27 Takeda Vaccines, Inc. Solid composition, freeze-drying method and glass vial
EP4362975A4 (en) * 2021-06-28 2025-05-14 VST LLC dba Medgene Labs SAPOVIRUS VACCINES
CN116789773B (zh) * 2022-11-30 2024-02-20 华北制药金坦生物技术股份有限公司 一种胞内表达病毒样颗粒的粗纯方法
WO2025077800A1 (en) * 2023-10-12 2025-04-17 Chengdu Kanghua Biological Products Co., Ltd. Purification of norovirus virus-like particles (vlps)
CN118126202B (zh) * 2024-05-07 2024-07-30 上海瑞宙生物科技有限公司 一种诺如病毒类病毒颗粒及其应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2833106B2 (ja) 1990-02-21 1998-12-09 株式会社島津製作所 液体クロマトグラフ
WO1994026087A2 (en) 1993-05-14 1994-11-24 Connor Kim C O Recombinant protein production and insect cell culture and process
ATE328068T1 (de) 1994-05-16 2006-06-15 Merck & Co Inc Papillomavirus vakzine
AR004464A1 (es) 1994-11-14 1998-12-16 Merck Sharp & Dohme Un metodo para producir una proteina de capside de papilomavirus
JP3316325B2 (ja) * 1994-12-20 2002-08-19 富士シリシア化学株式会社 ビール安定化処理用シリカゲル及びその製造方法並びにビールの安定化処理方法
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CA2269097C (en) 1996-11-08 2007-01-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
CA2302545C (en) 1997-09-05 2012-04-03 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
DE19823814A1 (de) 1998-05-27 1999-12-02 Octapharma Ag Ziegelbruecke Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie
PL347472A1 (en) 1998-08-14 2002-04-08 Merck & Co Inc Process for purifying human papillomavirus virus-like particles
KR20010093290A (ko) * 1999-02-05 2001-10-27 폴락 돈나 엘. 사람 파필로마바이러스 백신 제제
US6349843B1 (en) 1999-04-01 2002-02-26 The Vollrath Company Llc Pan removal ramp
EP1186890B1 (en) 1999-06-22 2013-01-02 Japan as Represented by Director-General of National Institute of Infectious Diseases Srsv detection kit
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP2003066021A (ja) 2001-08-28 2003-03-05 Hiroshi Shionoya 連続分取液体クロマトグラフィー装置とそれを用いる方法
US7041500B2 (en) 2002-02-14 2006-05-09 Novavax, Inc. Insect cell line
DK1501369T3 (en) 2002-04-26 2015-09-28 Genentech Inc Non-affinity purification of proteins
EP1585964A4 (en) 2002-08-28 2008-07-16 Introgen Therapeutics Inc CHROMATOGRAPHIC METHODS FOR PURIFYING ADENOVIRUSES
US7879338B2 (en) 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
US7481997B1 (en) 2004-02-12 2009-01-27 Montana State University Snow mountain virus genome sequence, virus-like particles and methods of use
WO2006138514A2 (en) 2005-06-16 2006-12-28 Children's Hospital Medical Center Novel norovirus particle for use as an antiviral or vaccine
EP1736538A1 (en) 2005-06-21 2006-12-27 Cytos Biotechnology AG Process for the preparative purification of virus-like-particles (VLPs)
AU2006335256B2 (en) 2005-11-22 2012-10-18 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
EP2275132B1 (en) 2005-12-29 2021-03-03 Boehringer Ingelheim Animal Health USA Inc. Multivalent PCV2 immunogenic compositions and methods of producing them
JP5683811B2 (ja) 2006-07-27 2015-03-11 タケダ ヴァクシーンズ, インコーポレイテッド キメラインフルエンザウイルス様粒子
ES2577833T3 (es) 2006-09-29 2016-07-19 Takeda Vaccines, Inc. Formulaciones de vacuna para norovirus
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
HUE028605T2 (en) 2007-03-14 2016-12-28 Takeda Vaccines Inc Cleaning virus-like particles
EP2027875A1 (en) * 2007-08-23 2009-02-25 Octapharma AG A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC)
SG10201601660YA (en) * 2007-09-18 2016-04-28 Takeda Vaccines Inc Method of conferring a protective immune response to norovirus
WO2009080781A1 (en) 2007-12-21 2009-07-02 Cytos Biotechnology Ag Process for clarifying cell homogenates
KR101793161B1 (ko) 2008-08-08 2017-11-03 다케다 백신즈 인코포레이티드 강화된 교차 반응성을 가진 복합체 캡시드 아미노산 서열들을 포함하는 바이러스-유사 입자들
AU2009319979B2 (en) 2008-11-03 2016-10-20 Takeda Vaccines, Inc. Improved methods for isolating enveloped virus-based VLPs free of infectious agents
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CA2787666A1 (en) 2010-01-21 2011-07-28 Ligocyte Pharmaceuticals, Inc. Targeted heterologous antigen presentation on calicivirus virus-like particles
JP5903101B2 (ja) 2010-09-20 2016-04-13 バイオ−ラッド ラボラトリーズ インコーポレーティッド クロマトグラフィーにおける生成物と複合体形成した夾雑物の分離方法
FI122520B (fi) 2010-10-15 2012-03-15 Vesna Blazevic Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena
CN102260651A (zh) 2011-06-24 2011-11-30 华中科技大学同济医学院附属协和医院 一种纯化病毒样颗粒蛋白的方法及其应用
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
JP2015015931A (ja) 2013-07-12 2015-01-29 株式会社Umnファーマ ウイルス様粒子を含む培養物の製造方法

Similar Documents

Publication Publication Date Title
US11629339B2 (en) Aseptic purification process for viruses
AU2008224877B2 (en) Virus like particle purification
KR101749779B1 (ko) 아데노바이러스 입자의 정제 방법
CA2482512A1 (en) Improved viral purification methods
CA2584142A1 (en) Improved viral purification methods
JP2017086090A5 (enExample)
HK1248763A1 (en) Aseptic purification process for viruses
CN106574252B (zh) 从细胞培养物中纯化脊髓灰质炎病毒的方法
WO2020153390A1 (ja) 活性炭材料を使用する工程を含む抗体精製方法
CN111304193A (zh) 一种大规模快速纯化质粒dna的方法
JP7282178B2 (ja) アフィニティークロマトグラフィーを用いたワクチン用ウイルスの精製方法
US11697800B2 (en) Method for the separation of virus compositions including depletion and purification thereof
JP2023529187A (ja) 混入dnaをより効果的に除去するための、アデノ随伴ウイルスの精製の強化
JP5389342B2 (ja) 吸着担体及び吸着担体の製造方法
CN111172048A (zh) 重组汉逊酵母表达的ca16病毒样颗粒的粗纯工艺、ca16病毒疫苗及其制备方法
CN111527202B (zh) So3色谱在病毒纯化方法中的应用
AU2013242822B2 (en) Virus like particle purification
CN120796207A (zh) 一种快速高效的慢病毒纯化方法
CA2548378A1 (en) A process for the preparation and purification of recombinant proteins
WO2021255835A1 (ja) アパタイトカラムを使用したウイルスの精製方法
AU2016269506A1 (en) Virus like particle purification